Furthermore, the combination of AKR1C3 and SLC7A11 is identified as a potent predictor of poor prognosis in HCC, highlighting the clinical relevance of these molecular interactions (Chen et al., 2023). The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.